by Karolinska Institutet Credit: Unsplash/CC0 Public Domain Thomas Hatschek, associate professor at the department of Oncology-Pathology, together with colleagues, has recently published an article in JAMA Oncology showing that a new treatment for breast cancer with an antibody linked to a cytotoxic drug is as good as the previous combination, but with fewer side effects. The development of...
